SCHEMBL4069682

SCHEMBL4069682

COc1ccc(-c2ccnc3[c]c[nH]c23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.45
CLK4 Q9HAZ1 1/20 0.44
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
DYRK1A Q13627 3/20 0.40
PTGS2 P35354 1/20 0.40
NPC1 O15118 3/20 0.39
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1763330 0.73 MAPK1 (0.48) CYP3A4CLK4CCNB2CDK1CCNB1
SCHEMBL28083154 0.70 CLK4 (0.53) CYP3A4CLK4CCNB2CDK1CCNB1
SCHEMBL27595494 0.70 CYP3A4 (0.47) CYP3A4CLK4CCNB2CDK1CCNB1
SCHEMBL27595550 0.67 CYP3A4 (0.45) CYP3A4CLK4CCNB2CDK1CCNB1
SCHEMBL878911 0.67 IKBKB (0.64) CLK4CDK5DYRK1A
SCHEMBL4867556 0.66 CLK4 (0.48) CYP3A4CLK4CCNB2CDK1CCNB1
SCHEMBL31232955 0.65 GLA (0.51) NPC1KMT2AMEN1KDM4ENPSR1
SCHEMBL15232687 0.65 DYRK1A (0.53) CYP3A4CLK4CCNB2CDK1CCNB1
SCHEMBL1823930 0.65 DYRK1A (0.53) CYP3A4CLK4DYRK1APTGS2NPC1
SCHEMBL23647565 0.64 DYRK1A (0.49) CYP3A4CLK4CCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363705-A4 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2009-08-12 EP disclosed
EP-1363705-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-11-26 EP disclosed
WO-2002062423-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-08-15 WO disclosed